Association of antibody-dependent neutrophil phagocytosis with distinct antibody glycosylation profiles following typhoid vaccination
Typhoid Vi-conjugate vaccines (Vi-TCV) have been developed to control typhoid fever in children in endemic regions. Previously, in a human challenge model of typhoid, Vi-TCV was administered prior to deliberate ingestion of Salmonella Typhi by healthy adult volunteers in the UK. Vi-specific antibody...
Main Authors: | Johnson, M, Stockdale, LK, de Haan, N, Wuhrer, M, Nouta, J, Koeleman, CAM, Clarke, J, Marinou, S, Shakya, M, Colin-Jones, R, Theiss-Nyland, K, Voysey, M, Jin, C, Pant, D, Jones, E, Kelly, S, Dongol, S, Karkey, A, Shrestha, S, Basnyat, B, Hill, J, Pollard, AJ |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2021
|
Similar Items
-
Distinct glycosylation and functional profile of typhoid vaccine-induced antibodies in a UK challenge study and Nepalese children
by: Stockdale, LK, et al.
Published: (2022) -
Assessing the impact of a vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepalese children: a protocol for a phase III, randomized control trial
by: Theiss-Nyland, K, et al.
Published: (2019) -
Logistics of implementing a large-scale typhoid vaccine trial in Kathmandu, Nepal
by: Colin-Jones, R, et al.
Published: (2019) -
Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
by: Shakya, M, et al.
Published: (2019) -
Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
by: Shakya, M, et al.
Published: (2019)